, Volume 67, Issue 1–2, pp 55–61 | Cite as

Determination of Celecoxib, Rofecoxib, Sodium Diclofenac and Niflumic Acid in Human Serum Samples by HPLC with DAD Detection

  • Natalia Navas
  • Rocio Ureña
  • Luis-Fermin Capitan-Vallvey


A reverse-phase high-performance liquid chromatographic method has been developed for the separation and simultaneous determination of two COX-2 inhibitors, celecoxib and rofecoxib, in addition to two well-known non-steroidal anti-inflammatory drugs (NSAIDs), sodium diclofenac and niflumic acid in human serum samples. Good chromatographic separation was achieved using a C18 bonded silica column applying a gradient with acetronitrile and water, from 15 to 60% acetonitrile. The mobile phase contained 0.1% trifluoroacetic acid as an organic modifier. Detection was made using a diode array detector (DAD) and the analytical parameters were established at the wavelength maximum in the UV spectrum of each drug. Linearity was studied up to 100.0 mg L−1. Calibration functions, quantification and detection limits, intra- and inter-day reproducibility and accuracy were estimated for each drug. Solid phase extraction was needed to separate and concentrate the drugs from human serum samples. The method was successfully applied to determine the drugs in human serum samples at levels of 1.0 mg L−1.


Column liquid chromatography Serum analysis Non-steroidal anti-inflammatory drugs Celecoxib and rofecoxib 



We thank Pharmacia (Pfizer) for kindly supplying the standard of CEL and Merck & Co., Inc. for kindly supplying the standard ROF.


  1. 1.
    Lewis PJ, Dollery CT (1983) Br Med Bull 39:281–284Google Scholar
  2. 2.
    Samad TA, Sapirstien A, Woolf CJ (2002) Trends Mol Med 8:390–396CrossRefGoogle Scholar
  3. 3.
    Garavito RM, Malkowski MG, DeWitt DL (2002) Prostaglandins Others Lipid Mediat 129:68–69Google Scholar
  4. 4.
    Smith WL, Garavito RM, Dewitt DL (1996) J Biol Chem 271:33157–33160CrossRefGoogle Scholar
  5. 5.
    Bombardier C, Laine L, Roicin A, Shapiro D, Burgos-Vargas R, Day R, Bosi M, Ilawkey CJ, Ilochberg MC, Kvien TK, Schnitzer TJ (2000) New Eng J Med 343:1520–1528CrossRefGoogle Scholar
  6. 6.
    Clemett D, Goa KL (2000) Drugs 59:957–980CrossRefGoogle Scholar
  7. 7.
    Cannon GW (1999) Drugs Today 35:487–496Google Scholar
  8. 8.
    Saha NR, Sajeev C, Jadhav PR, Patil SP, Srinivasan N (2002) J Pharm Biomed Anal 28:741–751CrossRefGoogle Scholar
  9. 9.
    Radhakrishna OT, Rao DS, Reddy GO (2001) J Pharm Biomed Anal 59:617CrossRefGoogle Scholar
  10. 10.
    Damani P, Bearzotti M, Cabezon A (2003) Anal Bioanal Chem 376:1141–1146CrossRefGoogle Scholar
  11. 11.
    Erk N, Altuntas TG (2004) Pharmazie 59:453–456Google Scholar
  12. 12.
    Rao NR, Meena S, Nagaraju D, Rao AR (2005) Biomed Chromatogr 19:362–368CrossRefGoogle Scholar
  13. 13.
    Gowik P, Julicher B, Uhlig S (1998) J Chromatogr B 716:221–232CrossRefGoogle Scholar
  14. 14.
    Sultan M, Stecher G, Stoeggi WM, Bakry R, Zaborski P, Huck CW, El-Kousy NM, Bonn GK (2005) Cur Med Chem 12:573–588Google Scholar
  15. 15.
    Sreenivasa RB, Murthy R, Prasanna SAL (1997) Eastern Pharmacist 40:47–49Google Scholar
  16. 16.
    Hercegova A, Polonsky J (1999) Pharmazie 54:479–486Google Scholar
  17. 17.
    Rao RN, Meena S, Rao AR (2005) J Pharm Biomed Anal 39:349–363CrossRefGoogle Scholar
  18. 18.
    Li K, Zhao FL, Yuan YS, Tan L (1995) J Liquid Chromatogr 18:2205–2216CrossRefGoogle Scholar
  19. 19.
    Lee HW, Won KJ, Cho SH, Ha YH, Park WS, Yim HT, Baek M, Rew JH, Yoon SH, Yim SV, Chung JH, Lee KT (2005) J Chromatogr B 821:215–220CrossRefGoogle Scholar
  20. 20.
    Aravind MK, Prescilla R, Ofenstein JP (2002) J Chromatogr Sci 40:26–28Google Scholar
  21. 21.
    Amini M, Hamedani MP, Vosooghi M, Nabavi M, Shafiee A (2005) Anal Bioanal Chem 381:1265–1268CrossRefGoogle Scholar
  22. 22.
    Jalalizadeh H, Amini M, Ziaee V, Safa A, Farsam H, Shafiee A (2004) J Pharm Biomed Anal 35:665–670CrossRefGoogle Scholar
  23. 23.
    Stomer E, Bauer S, Kirchheiner J, Brockmoller J, Roots I (2003) J Chromatogr B 783:207–212CrossRefGoogle Scholar
  24. 24.
    Savaser A, Oezkan Y, Oezkan C, Tas C, Oezcan S (2004) Anal Lett 37:81–97CrossRefGoogle Scholar
  25. 25.
    Zhang M, Moore GA, Gardiner SJ, Begg EJ (2004) J Chromatogr B 807:217–221CrossRefGoogle Scholar
  26. 26.
    Vintiloiu A, Mullet WM, Papp R, Ludda D, Kwong E (2005) J Chromatogr A 1082:150–157CrossRefGoogle Scholar
  27. 27.
    Hamama AK, Ray J, Day R, Richard O, Brien J (2005) J Chrom Sci 43:351–354Google Scholar
  28. 28.
    Analytical Methods Committee (1994) Analyst 119:2363CrossRefGoogle Scholar
  29. 29.
    Kimura K, Oishi H, Miura T, Shorro T (1987) Anal Chem 59:2331–2334CrossRefGoogle Scholar
  30. 30.
    Cuadros L, García-Campaña A, Linares C, Román M (1993) Anal Lett 26(6):1243–1246Google Scholar
  31. 31.
    Siu SSN, Yeung JHK, Lau TK (2000) Hum Reprod 15(11):2423–2425CrossRefGoogle Scholar
  32. 32.
    Verbruggen G, Veys EM, Malfait AM, Schatteman L, Wieme N, Nimmegeers J, Gerin MG, Broddelez C (1990) Clin Rheumatol 9:32–41CrossRefGoogle Scholar
  33. 33.
    Davies NM, Mclachlan AJ, Day RO, Williams KM (2000) Clin Pharmacokinet 38:225–242CrossRefGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlag/GWV Fachverlage GmbH 2007

Authors and Affiliations

  • Natalia Navas
    • 1
  • Rocio Ureña
    • 1
  • Luis-Fermin Capitan-Vallvey
    • 1
  1. 1.Solid Phase Spectrometry Research Group, Department of Analytical Chemistry, Faculty of SciencesUniversity of GranadaGranadaSpain

Personalised recommendations